Searchable abstracts of presentations at key conferences in endocrinology

ea0032p974 | Steroid metabolism and action | ECE2013

Effects of food components and the ratio of epitestosterone to testosterone on steroid glucuronidation

Jenkinson Carl , Barker James , Petroczi Andrea , Naughton Declan

The ratio of the glucuronidated epitestosterone (E) and testosterone (T), used in doping tests, is currently under question. The key enzyme involved in E metabolism is UGT2B7 in contrast to T which is mainly metabolised by UGT2B17. Previous results demonstrated that at very high concentrations E acts as a competitive inhibitor to UGT2B17. Similarly, the literature reports competitive inhibition of UGTs by NSAIDS and phenolics that are not substrates of UGT2B17. The aim of this...

ea0050p030 | Adrenal and Steroids | SFEBES2017

Influence of vitamin D on outcomes following burn injury: An observational cohort study

Al-Tarrah Khaled , Jenkinson Carl , Hewison Martin , Moiemen Naiem , Lord Janet

Introduction: Low levels of vitamin D are associated with higher mortality in critically ill patients. Studies on vitamin D levels in adult burn patients and their influence on clinical outcomes are scarce. Therefore, vitamin D status following thermal injury is often overlooked as its clinical implications are poorly understood.Aim: To examine the relationship of major thermal injury on the vitamin D axis and the influence of ...

ea0050p051 | Bone and Calcium | SFEBES2017

1,25-dihydroxyvitamin D deficiency in haemodialysis patients is corrected by vitamin D supplementation

Huish Sharon , Jenkinson Carl , Fletcher Simon , Dunn Janet , Hewison Martin , Bland Rosemary

Reduced renal synthesis of 1,25-dihydroxyvitamin D (1,25(OH)2D) from 25-hydroxyvitamin D (25OHD) in end stage renal disease (ESRD) results in low serum 1,25(OH)2D. This appears to be due to reduced renal cell function and elevated serum fibroblast growth factor 23 (FGF23). Treatment strategies have therefore focussed on 1,25(OH)2D or its synthetic analogues, alfacalcidol or paricalcitol. However this overlooks 25-hydroxyv...

ea0050p030 | Adrenal and Steroids | SFEBES2017

Influence of vitamin D on outcomes following burn injury: An observational cohort study

Al-Tarrah Khaled , Jenkinson Carl , Hewison Martin , Moiemen Naiem , Lord Janet

Introduction: Low levels of vitamin D are associated with higher mortality in critically ill patients. Studies on vitamin D levels in adult burn patients and their influence on clinical outcomes are scarce. Therefore, vitamin D status following thermal injury is often overlooked as its clinical implications are poorly understood.Aim: To examine the relationship of major thermal injury on the vitamin D axis and the influence of ...

ea0050p051 | Bone and Calcium | SFEBES2017

1,25-dihydroxyvitamin D deficiency in haemodialysis patients is corrected by vitamin D supplementation

Huish Sharon , Jenkinson Carl , Fletcher Simon , Dunn Janet , Hewison Martin , Bland Rosemary

Reduced renal synthesis of 1,25-dihydroxyvitamin D (1,25(OH)2D) from 25-hydroxyvitamin D (25OHD) in end stage renal disease (ESRD) results in low serum 1,25(OH)2D. This appears to be due to reduced renal cell function and elevated serum fibroblast growth factor 23 (FGF23). Treatment strategies have therefore focussed on 1,25(OH)2D or its synthetic analogues, alfacalcidol or paricalcitol. However this overlooks 25-hydroxyv...

ea0086oc1.4 | Bone and Calcium | SFEBES2022

Measurements of circulating conjugated and unconjugated vitamin D metabolites by enzyme hydrolysis combined with liquid chromatography mass spectrometry

Jenkinson Carl , Desai Reena , McLeod Malcolm , Wolf Mueller Jonathan , Hewison Martin , Handelsman David

Recent in-vitro studies have shown that vitamin D metabolites undergo conjugation reactions by sulfation and glucuronidation and may be important mechanisms for the inactivation, storage and excretion of analytes. However the circulating concentrations and clinical significance of phase II vitamin D conjugation is unclear as current analysis has almost exclusively been restricted to measuring their unconjugated metabolite forms. In this study we aimed to develop an analytical ...

ea0044p67 | Clinical biochemistry | SFEBES2016

Three minute run time LC-MS/MS method for separation and quantifying 25-hydroxyvitamin D from C3-epimers

Jenkinson Carl , Bradbury James , Taylor Angela , He Shan , Viant Mark , Hewison Martin

Vitamin D exists as two forms; D3 (UV) and D2 (plant derived). Measuring the metabolite 25-hydroxyvitamin D (25OHD) is routinely applied in research and clinical laboratories to assess vitamin D status. The Institute of Medicine and Society for Endocrinology have previously set recommended vitamin D guidelines based on combined 25OHD3 and 25OHD2 serum concentrations. In order to achieve accurate quantitation of these metabolites, the respective C3 epimers must be separately qu...

ea0038p362 | Reproduction | SFEBES2015

Vitamin D metabolic profiling across pregnancy

Susarla Radhika , Jenkinson Carl , Tamblyn Jennifer , Keevil Brian , Chan Shiao-Yng , Kilby Mark , Hewison Martin

Vitamin D-deficiency during pregnancy has been associated with increased complications of pregnancy including a high risk of pre-eclampsia (PET). Current analysis of vitamin D ‘status’ is based exclusively on analysis of maternal serum 25-hydroxyvitamin D3 (25(OH)D3), the circulating precursor form of vitamin D. We hypothesised that comprehensive profiling of vitamin D metabolites may provide a more accurate determination of vitamin D function i...

ea0038p413 | Steroids | SFEBES2015

Profiling of multiple vitamin D metabolites in a healthy human cohort by high-throughput liquid chromatography–tandem mass spectrometry analysis

Jenkinson Carl , Taylor Angela , Susarla Radhika , Tamblyn Jennifer , Hassan-Smith Zaki , Keevil Brian , Hewison Martin

Although a complex metabolic pathway for vitamin D exists, serum measurement of inactive 25-hydroxyvitamin D3 (25OHD3) continues to be the most common determinant of vitamin D ‘status’. However, several other metabolites contribute to the physiological role of vitamin D, notably the active form 1α,25-dihydroxyvitamin D (1α,25(OH)2D3), inactive 3-epi-25OHD3 and chiral 23R and 24R,25(OH)2D3 metabolites. Quantification of these additional metabolites could pro...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...